SEARCH

SEARCH BY CITATION

References

  • Aga M., Johnson C. J., Hart A. P., Guadarrama A. G., Suresh M., Svaren J., Bertics P. J. and Darien B. J. (2002) Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X(7). J. Leukoc. Biol. 72, 222232.
  • Anselmi F., Hernandez V. H., Crispino G. et al. (2008) ATP release through connexin hemichannels and gap junction transfer of second messengers propagate Ca2+ signals across the inner ear. Proc. Natl Acad. Sci. USA 105, 1877018775.
  • Bakshi P., Jin C., Broutin P., Berhane B., Reed J. and Mullan M. (2009) Structural optimization of a CXCR2-directed antagonist that indirectly inhibits gamma-secretase and reduces Abeta. Bioorg. Med. Chem. 17, 81028112.
  • Beigi R., Kobatake E., Aizawa M. and Dubyak G. R. (1999) Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am. J. Physiol. 276, C267C278.
  • Belcheva M. M., Clark A. L., Haas P. D., Serna J. S., Hahn J. W., Kiss A. and Coscia C. J. (2005) Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes. J. Biol. Chem. 280, 2766227669.
  • Blasi E., Barluzzi R., Bocchini V., Mazzolla R. and Bistoni F. (1990) Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 27, 229237.
  • Bodin P. and Burnstock G. (2001) Purinergic signalling: ATP release. Neurochem. Res. 26, 959969.
  • Bradford M. D. and Soltoff S. P. (2002) P2X7 receptors activate protein kinase D and p42/p44 mitogen-activated protein kinase (MAPK) downstream of protein kinase C. Biochem. J. 366, 745755.
  • Braun N., Zhu Y., Krieglstein J., Culmsee C. and Zimmermann H. (1998) Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J. Neurosci. 18, 48914900.
  • Chessell I. P., Hatcher J. P., Bountra C. et al. (2005) Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114, 386396.
  • Chow C. W., Rincon M., Cavanagh J., Dickens M. and Davis R. J. (1997) Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science 278, 16381641.
  • De Paola M., Buanne P., Biordi L., Bertini R., Ghezzi P. and Mennini T. (2007) Chemokine MIP-2/CXCL2, acting on CXCR2, induces motor neuron death in primary cultures. Neuroimmunomodulation 14, 310316.
  • Dean J. L., Sully G., Clark A. R. and Saklatvala J. (2004) The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell. Signal. 16, 11131121.
  • Diab A., Abdalla H., Li H. L. et al. (1999) Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis. Infect. Immun. 67, 25902601.
  • Ferrari D., Chiozzi P., Falzoni S., Hanau S. and Di Virgilio F. (1997a) Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185, 579582.
  • Ferrari D., Wesselborg S., Bauer M. K. and Schulze-Osthoff K. (1997b) Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65. J. Cell Biol. 139, 16351643.
  • Ferrari D., Stroh C. and Schulze-Osthoff K. (1999) P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. J. Biol. Chem. 274, 1320513210.
  • Franke H., Gunther A., Grosche J., Schmidt R., Rossner S., Reinhardt R., Faber-Zuschratter H., Schneider D. and Illes P. (2004) P2X7 receptor expression after ischemia in the cerebral cortex of rats. J. Neuropathol. Exp. Neurol. 63, 686699.
  • Genot E., Cleverley S., Henning S. and Cantrell D. (1996) Multiple p21ras effector pathways regulate nuclear factor of activated T cells. EMBO J. 15, 39233933.
  • Geraldes P., Hiraoka-Yamamoto J., Matsumoto M., Clermont A., Leitges M., Marette A., Aiello L. P., Kern T. S. and King G. L. (2009) Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat. Med. 15, 12981306.
  • Greenberg S., Di Virgilio F., Steinberg T. H. and Silverstein S. C. (1988) Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms. J. Biol. Chem. 263, 1033710343.
  • Gschwendt M., Dieterich S., Rennecke J., Kittstein W., Mueller H. J. and Johannes F. J. (1996) Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 392, 7780.
  • Hide I., Tanaka M., Inoue A., Nakajima K., Kohsaka S., Inoue K. and Nakata Y. (2000) Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J. Neurochem. 75, 965972.
  • Ho I. C., Hodge M. R., Rooney J. W. and Glimcher L. H. (1996) The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973983.
  • Honore P., Donnelly-Roberts D., Namovic M. T. et al. (2006) A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dim-ethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J. Pharmacol. Exp. Ther. 319, 13761385.
  • Humphreys B. D., Rice J., Kertesy S. B. and Dubyak G. R. (2000) Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J. Biol. Chem. 275, 2679226798.
  • Igarashi H., Yokofujita J., Murakami K., Okada A. and Kuroda M. (2003) Microglial ecto-Ca(2+)-ATPase activity in a rat model of focal homologous blood clot embolic cerebral ischemia: an enzyme histochemical study. Brain Res. Bull. 60, 93104.
  • Im S. H. and Rao A. (2004) Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling. Mol Cells 18, 19.
  • Inoue K. (2002) Microglial activation by purines and pyrimidines. Glia 40, 156163.
  • James G. and Butt A. M. (2002) P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system. Eur. J. Pharmacol. 447, 247260.
  • Kang J., Yang M., Jou I. and Joe E. (2001) Identification of protein kinase C isoforms involved in interferon-gamma-induced expression of inducible nitric oxide synthase in murine BV2 microglia. Neurosci. Lett. 299, 205208.
  • Karin M., Liu Z. and Zandi E. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240246.
  • Kataoka A., Tozaki-Saitoh H., Koga Y., Tsuda M. and Inoue K. (2009) Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT. J. Neurochem. 108, 115125.
  • Kerstetter A. E., Padovani-Claudio D. A., Bai L. and Miller R. H. (2009) Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Exp. Neurol. 220, 4456.
  • Khabar K. S. (2005) The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. J. Interferon Cytokine Res. 25, 110.
  • Kim D. S., Han J. H. and Kwon H. J. (2003) NF-kappaB and c-Jun-dependent regulation of macrophage inflammatory protein-2 gene expression in response to lipopolysaccharide in RAW 264.7 cells. Mol. Immunol. 40, 633643.
  • Koizumi S., Shigemoto-Mogami Y., Nasu-Tada K. et al. (2007) UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 446, 10911095.
  • Le Feuvre R. A., Brough D., Touzani O. and Rothwell N. J. (2003) Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J. Cereb. Blood Flow Metab. 23, 381384.
  • Luo Y., Fischer F. R., Hancock W. W. and Dorf M. E. (2000) Macrophage inflammatory protein-2 and KC induce chemokine production by mouse astrocytes. J. Immunol. 165, 40154023.
  • Martiny-Baron G., Kazanietz M. G., Mischak H., Blumberg P. M., Kochs G., Hug H., Marme D. and Schachtele C. (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268, 91949197.
  • McLarnon J. G., Ryu J. K., Walker D. G. and Choi H. B. (2006) Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus. J. Neuropathol. Exp. Neurol. 65, 10901097.
  • Nakajima K., Shimojo M., Hamanoue M., Ishiura S., Sugita H. and Kohsaka S. (1992) Identification of elastase as a secretory protease from cultured rat microglia. J. Neurochem. 58, 14011408.
  • Negishi H., Ohba Y., Yanai H., Takaoka A., Honma K., Yui K., Matsuyama T., Taniguchi T. and Honda K. (2005) Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl Acad. Sci. USA 102, 1598915994.
  • Norenberg W., Langosch J. M., Gebicke-Haerter P. J. and Illes P. (1994) Characterization and possible function of adenosine 5′-triphosphate receptors in activated rat microglia. Br. J. Pharmacol. 111, 942950.
  • Numahata K., Komagata T., Hirasawa N., Someya K., Xiao Y. Q. and Ohuchi K. (2003) Analysis of the mechanism regulating the stability of rat macrophage inflammatory protein-2 mRNA in RBL-2H3 cells. J. Cell. Biochem. 90, 976986.
  • Ortega-Perez I., Cano E., Were F., Villar M., Vazquez J. and Redondo J. M. (2005) c-Jun N-terminal kinase (JNK) positively regulates NFATc2 transactivation through phosphorylation within the N-terminal regulatory domain. J. Biol. Chem. 280, 2086720878.
  • Parenty G., Appelbe S. and Milligan G. (2008) CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer. Biochem. J. 412, 245256.
  • Parvathenani L. K., Tertyshnikova S., Greco C. R., Roberts S. B., Robertson B. and Posmantur R. (2003) P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer’s disease. J. Biol. Chem. 278, 1330913317.
  • Pellegatti P., Falzoni S., Pinton P., Rizzuto R. and Di Virgilio F. (2005) A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol. Biol. Cell 16, 36593665.
  • Pellegatti P., Raffaghello L., Bianchi G., Piccardi F., Pistoia V. and Di Virgilio F. (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS ONE 3, e2599.
  • Pelus L. M. and Fukuda S. (2006) Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. Exp. Hematol. 34, 10101020.
  • Peng W., Cotrina M. L., Han X. et al. (2009) Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc. Natl Acad. Sci. USA 106, 1248912493.
  • Popivanova B. K., Koike K., Tonchev A. B., Ishida Y., Kondo T., Ogawa S., Mukaida N., Inoue M. and Yamashima T. (2003) Accumulation of microglial cells expressing ELR motif-positive CXC chemokines and their receptor CXCR2 in monkey hippocampus after ischemia-reperfusion. Brain Res. 970, 195204.
  • Porter C. M., Havens M. A. and Clipstone N. A. (2000) Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization. J. Biol. Chem. 275, 35433551.
  • Potucek Y. D., Crain J. M. and Watters J. J. (2006) Purinergic receptors modulate MAP kinases and transcription factors that control microglial inflammatory gene expression. Neurochem. Int. 49, 204214.
  • Ramnath R. D., Sun J., Adhikari S., Zhi L. and Bhatia M. (2008) Role of PKC-delta on substance P-induced chemokine synthesis in pancreatic acinar cells. Am. J. Physiol. Cell Physiol. 294, C683C692.
  • Rao A. (1994) NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15, 274281.
  • Rao A., Luo C. and Hogan P. G. (1997) Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707747.
  • Roehrl M. H., Kang S., Aramburu J., Wagner G., Rao A. and Hogan P. G. (2004) Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules. Proc. Natl Acad. Sci. USA 101, 75547559.
  • Sanz J. M., Chiozzi P., Ferrari D., Colaianna M., Idzko M., Falzoni S., Fellin R., Trabace L. and Di Virgilio F. (2009) Activation of microglia by amyloid {beta} requires P2X7 receptor expression. J. Immunol. 182, 43784385.
  • Shigemoto-Mogami Y., Koizumi S., Tsuda M., Ohsawa K., Kohsaka S. and Inoue K. (2001) Mechanisms underlying extracellular ATP-evoked interleukin-6 release in mouse microglial cell line, MG-5. J. Neurochem. 78, 13391349.
  • Sii-Felice K., Pouponnot C., Gillet S., Lecoin L., Girault J. A., Eychene A. and Felder-Schmittbuhl M. P. (2005) MafA transcription factor is phosphorylated by p38 MAP kinase. FEBS Lett. 579, 35473554.
  • Slepko N., Patrizio M. and Levi G. (1999) Expression and translocation of protein kinase C isoforms in rat microglial and astroglial cultures. J. Neurosci. Res. 57, 3338.
  • Steinberg T. H., Newman A. S., Swanson J. A. and Silverstein S. C. (1987) ATP4- permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J. Biol. Chem. 262, 88848888.
  • Suzuki T., Hide I., Ido K., Kohsaka S., Inoue K. and Nakata Y. (2004) Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J. Neurosci. 24, 17.
  • Tessier P. A., Naccache P. H., Clark-Lewis I., Gladue R. P., Neote K. S. and McColl S. R. (1997) Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J. Immunol. 159, 35953602.
  • Tozaki-Saitoh H., Tsuda M., Miyata H., Ueda K., Kohsaka S. and Inoue K. (2008) P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J. Neurosci. 28, 49494956.
  • Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M. W. and Inoue K. (2003) P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778783.
  • Valles A., Grijpink-Ongering L., De Bree F. M., Tuinstra T. and Ronken E. (2006) Differential regulation of the CXCR2 chemokine network in rat brain trauma: implications for neuroimmune interactions and neuronal survival. Neurobiol. Dis. 22, 312322.
  • Wang X., Arcuino G., Takano T. et al. (2004) P2X7 receptor inhibition improves recovery after spinal cord injury. Nat. Med. 10, 821827.
  • Widmer U., Manogue K. R., Cerami A. and Sherry B. (1993) Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine superfamily of proinflammatory cytokines. J. Immunol. 150, 49965012.
  • Yang T. T. and Chow C. W. (2003) Transcription cooperation by NFAT.C/EBP composite enhancer complex. J. Biol. Chem. 278, 1587415885.
  • Yang T. T., Xiong Q., Enslen H., Davis R. J. and Chow C. W. (2002) Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases. Mol. Cell. Biol. 22, 38923904.
  • Yiangou Y., Facer P., Durrenberger P., Chessell I. P., Naylor A., Bountra C., Banati R. R. and Anand P. (2006) COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol. 6, 12.
  • Youn H. D., Chatila T. A. and Liu J. O. (2000) Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 19, 43234331.